For many of us, we’re entering week 8 of Work From Home during the Covid-19 crisis. It’s been inspiring to see all those in the healthcare communications universe innovate and remain motivated to continue our critical work during these challenging times. It’s fair to say that now, more than ever, the role of effectively communicating the research, development, administration and efficacy of drug therapies is paramount to successfully navigating the world through this pandemic and beyond. We invite all families to join us virtually, for our June 18th Med Ad News Manny Awards #FamilyStyle! This year’s Manny Awards program will be designed to entertain, engage and educate our growing healthcare communications family. Set your calendars and make a night of it for the entire family to get dressed up for a virtual Black Tie event!
Scientists, researchers, health officials, regulatory agencies, governments, businesses, universities, and many others across the globe are searching for ways to defeat the coronavirus pandemic.
While the healthcare industry looks for ways to combat COVID-19, the beat goes on for drug manufacturers to continue developing and seeking marketing approval for medicines to treat many diseases and conditions. Here is a look at some of the most notable U.S. new drug approvals from Jan. 1 through April 17, 2020.
As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.
Executive management from the 2019 Manny Award agency and network winners & finalists provide expert insight on healthcare industry topics and predictions.
Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.
This annual compilation reviews new developments, trends and outlooks in areas such as biotechnology, biosimilars, biopharmaceuticals, biologics, biomarkers and biosimulation.
PulseCX is a full-service, independent, mid-sized healthcare marketing agency located just outside Philadelphia. PulseCX specializes in optimizing the customer experience (CX) for pharmaceutical brands, medical devices, and OTC products.
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
The return on R&D investment for leading biopharmaceutical manufacturers fell to a nine-year low while the U.S. FDA approved a record-breaking amount of novel medicines during 2018.